.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
AstraZeneca
Accenture
Express Scripts
QuintilesIMS
Moodys
US Department of Justice
Baxter
Merck
McKesson

Generated: September 26, 2017

DrugPatentWatch Database Preview

Ferring Company Profile

« Back to Dashboard

What is the competitive landscape for FERRING, and when can generic versions of FERRING drugs launch?

FERRING has twenty-four approved drugs.

There are sixteen US patents protecting FERRING drugs.

There are one hundred and fifty-one patent family members on FERRING drugs in thirty-eight countries.

Summary for Applicant: Ferring

Patents:16
Tradenames:24
Ingredients:14
NDAs:24
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ferring
FIRMAGON
degarelix acetate
POWDER;SUBCUTANEOUS022201-002Dec 24, 2008RXYesYes► Subscribe► SubscribeYY ► Subscribe
Ferring Pharms As
LYSTEDA
tranexamic acid
TABLET;ORAL022430-001Nov 13, 2009ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Ferring Pharms Inc
CERVIDIL
dinoprostone
INSERT, EXTENDED RELEASE;VAGINAL020411-001Mar 30, 1995RXYesYes► Subscribe► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
INJECTABLE;INJECTION018938-002Apr 25, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP (NEEDS NO REFRIGERATION)
desmopressin acetate
SPRAY, METERED;NASAL017922-003Aug 7, 1996ABRXYesYes► Subscribe► Subscribe► Subscribe
Ferring
A.P.L.
gonadotropin, chorionic
INJECTABLE;INJECTION017055-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ferring Pharms As
LYSTEDA
tranexamic acid
TABLET;ORAL022430-001Nov 13, 2009ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Ferring
CHORIONIC GONADOTROPIN
gonadotropin, chorionic
INJECTABLE;INJECTION017016-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ferring
LUTREPULSE KIT
gonadorelin acetate
INJECTABLE;INJECTION019687-002Oct 10, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Ferring Pharms As
LYSTEDA
tranexamic acid
TABLET;ORAL022430-001Nov 13, 2009ABRXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Ferring

Paragraph IV activity for FERRING drugs

Drugname Dosage Strength Tradename Submissiondate
sodium picosulfate, magnesium oxide and anhydrous citric acid
Oral Solution10 mg, 3.5 g, and 12 g
PREPOPIK
5/21/2014
tranexamic acid
Tablets650 mg
LYSTEDA
5/24/2011

Non-Orange Book Patents for Ferring

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,214,798 GnRH antagonists being modified in positions 5 and 6► Subscribe
8,841,081Method of treating metastatic stage prostate cancer► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ferring Drugs

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2009047633► Subscribe
European Patent Office2799085► Subscribe
Norway994906► Subscribe
South Korea20100123714► Subscribe
Poland336213► Subscribe
Portugal2505204► Subscribe
Israel223124► Subscribe
Taiwan505658► Subscribe
Russian Federation2010133480► Subscribe
Japan2011511786► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Ferring Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0395Netherlands► Subscribe300395, 20180413, EXPIRES: 20230412
2009000033Germany► SubscribePRODUCT NAME: DEGARELIX, GGF. IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES DAVON, WIE DEM ACETAT; REGISTRATION NO/DATE: EU/1/08/504/001-002 20090217
1003774/01Switzerland► SubscribePRODUCT NAME: DEGARELIX; REGISTRATION NUMBER/DATE: SWISSMEDIC 59455 12.02.2010
C020/2009Ireland► SubscribeSPC020/2009: 20091119, EXPIRES: 20230412
C0037Belgium► SubscribePRODUCT NAME: OESTROGENES EQUINS CONJUGUES; ACETATE DE MEDROXYPROGESTERONE; NAT. REGISTRATION NO/DATE: NL 19569 19950301; FIRST REGISTRATION: CH - 52647 01 010 19940826
C/GB09/028United Kingdom► SubscribePRODUCT NAME: DEGARELIX OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT SUCH AS THE ACETATE; REGISTERED: UK EU/1/08/504/001 20090217; UK EU/1/08/504/002 20090217
585Luxembourg► SubscribePRODUCT NAME: DEGARELIX, EVENTUELLEMENT UN SEL PHARMACEUTIQUEMENT ACCEPTABE, TEL QUE L'ACETATE (FIRMAGON); REG. DATE: 20090217
C0028France► SubscribePRODUCT NAME: DEGARELIX, SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, EN PARTICULIER ACETATE; REGISTRATION NO/DATE IN FRANCE: EU/1/08/504/001 DU 20090217; REGISTRATION NO/DATE AT EEC: EU/1/08/504/001 DU 20090217
2Finland► Subscribe
2009005,C1003774Lithuania► SubscribePRODUCT NAME: DEGARELIXUM ACETAT; REGISTRATION NO/DATE: EU/1/08/504/001, 2009 02 17 EU/1/08/504/002 20090217
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Mallinckrodt
AstraZeneca
UBS
Chinese Patent Office
Healthtrust
Farmers Insurance
Argus Health
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot